An Inheritable variant of the innate immune receptor melanoma differentiation-associated gene 5 promotes clearance of hepatitis C virus.
An Inheritable variant of the innate immune receptor melanoma differentiation-associated gene 5 promotes clearance of hepatitis C virus.
复制标题
先天免疫受体黑色素瘤分化相关基因 5 的可遗传变体可促进丙型肝炎病毒的清除。
DOI:
10.1002/hep.27439
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Modis,Yorgo
中科院分区:
文献类型:
--
作者:
Modis,Yorgo
As a leading cause of chronic liver disease and cancer, hepatitis C virus (HCV) is a serious and persistent global health threat. 1 In their article in the current issue of HEPATOLOGY, Hoffmann et al. identified the less frequent variant of a singlenucleotide polymorphism (SNP) in the melanoma differentiation-associated gene 5 (mda5) gene that is associated with a significantly higher rate of spontaneous recovery from hepatitis C, as well as a lower rate of chronic infection in HCV patients. 2 The more efficient clearance of HCV in patients harboring this minor allele of mda5 stems from increased cytokine secretion by cells in response to double-stranded RNA (dsRNA). This suggests that the signaling activity of MDA5 in response to cytoplasmic dsRNA, which is a hallmark of HCV infection, is enhanced in the protective variant of MDA5. This new finding implicates MDA5 in the natural course of HCV infection. Most enveloped viruses either deliver an RNA genome into the cytoplasm of the host cell or generate RNA in the cytoplasm during replication or transcription of the viral genome. Infection by these viruses is primarily detected by a pair of essential immune sensors, retinoic acid-inducible gene 1 (RIG-I) andMDA5. 3-5 Binding of cytoplasmic viral RNA by RIGI or MDA5 induces a conformational change in the sensor protein that directs the cooperative assembly of large oligomeric signaling platforms, leading to the recruitment and activation of the signaling adaptor, mitochondrial antiviral-signaling protein (MAVS; interferon [IFN] promoter stimulator 1 IPS-1). 6-8 The rapidly ensuing inflammatory response culminates in activation of the nuclear factor kappa B–and type I IFN-signaling pathways. This response is one of the first and most important lines of defense against infection and is responsible for the activation of the adaptive immune system. 9 Therefore, RIG-I and MDA5 play pivotal roles as master regulators of inflammation. HCV is an enveloped RNA virus known to be sensed and controlled by the RIG-I-like receptor (RLR)-signaling pathway. Indeed, Huh-7.5 cells have a mutation in RIG-I that inactivates RIG-I signaling that renders them much more susceptible to HCV replication. 10, 11 However, MDA5 had not, until now, been directly implicated in the antiviral response against HCV. Notably, the downstream signaling adaptor of both RIG-I and MDA5, MAVS, is cleaved by the nonstructural 3/4A protease of HCV. 12, 13 Indeed, MAVS—and not the RLRs themselves—is the primary target of viral factors for inhibiting RLR signaling. 8 The study by Hoffmann et al. provides the first evidence that MDA5 is directly involved in anti-HCV signaling.